An Open, Randomised, Parallel-Group, Multicentre Trial to Compare the Efficacy of a Stratified Treatment Regimen for Acute Migraine Attacks, in whichPatients Receive Therapy According to the Grade of their Migraine Disability at Baseline, Assessed by the MIDAS Questionnaire, with that of 2 Other Treatment Regimens, in which Patients Receive Standard Therapy that may be altered after 3 Attacks (Stepped Care) or within Individual Attacks (Staged Care).
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Dec 2013 by AstraZeneca
No locations available